Global Fosfomycin Calcium Market: Overview
Fosfomycin calcium is a bactericidal agent with low toxicity levels and low cross-resistance level with other antibiotics. Known simply as fosfomycin or oral fosfomycin, it acts as an anti-infective agent by killing sensitive bacteria present in the affected body part. This substance exhibits high level of activity when used against gram positive and gram negative bacteria. White or yellow colored in the powdered form, fosfomycin can be used as an additive in drinking water and animal feed.
Request Brochure –
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4511
A clear, lucid analysis of the crucial factors accelerating and inhibiting the growth of the global market for fosfomycin calcium has been provided in the report. The major market trends and developments in the competitive landscape have been discussed, alongside a detailed analysis of the key market vendors and their business tactics such as partnerships, product innovation, and mergers. An analysis of the value chain, detailed descriptions of the key product and application segments, and market attractiveness are also included in the report.
Global Fosfomycin Calcium Market: Drivers and Restraints
Several studies such as clinical trials and case reports that incorporate data for patients of all ages, ranging from children to elderly populace suffering from disorders such as cystitis, pyelonephritis, gastrointestinal infections, and UTIs have revealed the efficiency of fosfomycin calcium. It has also been found to be useful in treating infections caused by several multidrug-resistant bacteria including penicillin-resistant pneumococci, vancomycin-resistant enterococci, and methicillin-resistant S.aureus. Tobramycin is used in combination with fosfomycin calcium in the treatment of lung infections in patients suffering from cystic fibrosis.
Request COVID Analysis on Fosfomycin Calcium Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=4511
Moreover, when 28 patients with chronic sinusitis were administered with fosfomycin calcium as a nebulized treatment, it led to reduction of symptoms in 22 of them. Fosfomycin calcium can also be a viable alternative replacing fluoroquinolones in the treatment of chronic bacterial prostatitis, finds a small study that was presented at Interscience Conference on Antimicrobial Agents and Chemotherapy held in San Diego during 2015.
In this study conducted by Ilias Karaiskos, MD, from the Hygeia General Hospital in Greece, a daily dosage of 3gms for a week, and then 3gms per 48 hours for a 6 week period was given orally to 20 patients. 85% of these patients, displayed signs of improved or resolved infection. The positive results of such research projects could pave the way for further expansion of the market in the future.
Request Customization on Fosfomycin Calcium Market Report –
https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=4511
However, side effects such as nausea, dizziness, and gastrointestinal disturbances incurred by fosfomycin calcium-drugs might inhibit the growth of the global market for fosfomycin calcium. Nonetheless, the expansion of the market is assured by the ceaseless efforts of the market players who are attempting to explore the emerging markets.
Global Fosfomycin Calcium Market: Regional Outlook
Asia Pacific, being the fastest growing region, promises considerable growth opportunities. India and China, exhibiting high demand for fosfomycin calcium are expected emerge as the key contributors to revenue generated by the Asia Pacific market. Countries such as Brazil, Germany, Japan, South Africa, France, and Spain have been using fosfomycin calcium on a large scale. North American region is also likely to register significant growth, thanks to the adoption of fosfomycin calcium in the treatment of uncomplicated urinary tract infection (UTI). Europe has also been displaying increasing demand for fosfomycin calcium, which is sold for oral use under different brand names.
Pre Book Fosfomycin Calcium Market Report –
https://www.transparencymarketresearch.com/checkout.php?rep_id=4511<ype=S
Companies mentioned in the research report
FarmaSino Pharmaceuticals (Jiangsu) Co., Ltd., Ercros S.A., AdvaCare Pharma, China Sinopharm International Shanghai Co., Ltd., Serendex Pharmaceuticals A/S, Northeast Pharmaceutical Group Co., Ltd., SINTOFARM FARMACEUTICI S.p.A., and Mingshui Fukang Chemical Co., Ltd. are some of the major companies operating in the global market for fosfomycin calcium.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.”
Contact
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com
It includes the size, share, growth, trends, key players, segments and regional analysis in detail during the study year 2020-2027.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the fosfomycin trometamol powder market include Zambon, Northeast Pharm, Hunan Huana Pharmaceuticals, Xunda Pharma, FarmaSino Pharmaceutical, Guilin Hwasun.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Fosfomycin Trometamol Powder Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/fosfomycin-trometamol-powder-market/download-sampleMarket DynamicsUncomplicated urinary tract infection (UTI) being of the most common health condition requiring therapeutic intervention and increased resistance to commonly used antibiotics are the main stimulating factors for market growth.
Single-dose Fosfomycin being increasingly considered as a first-line empirical treatment of uncomplicated lower UTIs will benefit market growth.
The global issue of advancing antimicrobial resistance and proposal for further uses will create new market growth opportunities.
Large-scale production of Fosfomycin using heterologous technologies will be a market booster.
Further, this report also highlights the regional and country-level market analysis.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the fosfomycin trometamol powder market include Zambon, Northeast Pharm, Hunan Huana Pharmaceuticals, Xunda Pharma, FarmaSino Pharmaceutical, Guilin Hwasun.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Fosfomycin Trometamol Powder Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/fosfomycin-trometamol-powder-market/download-sampleMarket DynamicsUncomplicated urinary tract infection (UTI) being of the most common health condition requiring therapeutic intervention and increased resistance to commonly used antibiotics are the main stimulating factors for market growth.
Single-dose Fosfomycin being increasingly considered as a first-line empirical treatment of uncomplicated lower UTIs will benefit market growth.
The global issue of advancing antimicrobial resistance and proposal for further uses will create new market growth opportunities.
The use of this antibiotic to treat some instances of prostate infections will enhance market share.
